Alvotech (ALVOW) Other Non-Current Liabilities (2020 - 2025)
Alvotech (ALVOW) reported Other Non-Current Liabilities of $210.2 million for Q3 2025, up 15.28% on a YoY basis from $182.4 million in Q3 2024, and up 233.67% quarter-over-quarter from $63.0 million in Q2 2025.
Alvotech (ALVOW) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends
Alvotech has reported Other Non-Current Liabilities for 6 years, with the latest figure at $210.2 million in Q3 2025.
- For the quarter ending Q3 2025, Other Non-Current Liabilities rose 15.28% year-over-year to $210.2 million; the trailing twelve-month figure through Sep 2025 stood at $210.2 million (up 15.28% YoY), and the FY2024 full-year result was $210.2 million, down 59.62% from the prior year.
- Other Non-Current Liabilities for Q3 2025 stood at $210.2 million, up from $63.0 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $520.6 million in Q1 2023, with the low at $11571.0 in Q4 2021.
- Historically, Other Non-Current Liabilities has averaged $250.5 million across 5 years, with a median of $210.2 million in 2024.
- Annual changes were most pronounced in 2021 — Other Non-Current Liabilities sank 100.0% — and 2022, when it jumped 3285977.26%.
- Alvotech's Other Non-Current Liabilities stood at $11571.0 in 2021, then jumped by 3285977.26% to $380.2 million in 2022, then jumped by 36.9% to $520.6 million in 2023, then plunged by 59.62% to $210.2 million in 2024, then changed by 0.0% to $210.2 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $210.2 million (Q3 2025), $63.0 million (Q2 2025), and $210.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Alvotech | - | - | -22.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 210.22 Mn |
| Jun 30, 2025 | 63.00 Mn |
| Mar 31, 2025 | 210.22 Mn |
| Dec 31, 2024 | 210.22 Mn |
| Sep 30, 2024 | 182.36 Mn |
| Jun 30, 2024 | 201.67 Mn |
| Mar 31, 2024 | 330.98 Mn |
| Dec 31, 2023 | 520.55 Mn |
| Jun 30, 2023 | 229.05 Mn |
| Mar 31, 2023 | 520.58 Mn |
| Dec 31, 2022 | 380.23 Mn |
| Jun 30, 2022 | 197.47 Mn |
| Dec 31, 2021 | 11,571.00 |
| Dec 31, 2020 | 534.69 Mn |